NCT05917639

Brief Summary

How health-related information is communicated affects what is understood and might influence how people make decisions and how confident they feel in participating in clinical shared decision-making. The CICERO trial will compare three different communication tools providing information on fictional interventions for a common medical problem (i.e. social anxiety disorder) both in terms of how well interventions work (benefit) and also possible harms associated (risk). The three communication tools ("Summary of Findings table", "Kilim plot", and "Vitruvian plot") differ in how they present information: exclusively written, primarily written and partially graphical, or mixed written and visual. Each participant will be asked to go through one clinical scenario. The investigators will ask participants to familiarise themselves with the tool they have been allocated to (either a plot or a table) and then answer some validated questionnaires to measure how useful and efficient the communication strategy was. The entire study occurs online in a single study session (about 20 minutes). The results of the CICERO trial will inform how to communicate research findings to the general population, facilitating their implementation in clinical shared decision-making.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,178

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 31, 2023

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 5, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 26, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 27, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 27, 2023

Completed
Last Updated

December 18, 2023

Status Verified

December 1, 2023

Enrollment Period

6 months

First QC Date

June 5, 2023

Last Update Submit

December 15, 2023

Conditions

Keywords

shared decision-making

Outcome Measures

Primary Outcomes (1)

  • Decisional Conflict Scale, low literacy version

    Higher scores indicate worse outcomes (min = 0; max = 100).

    through study completion, an average of 20 minutes

Secondary Outcomes (3)

  • Decision Self-Efficacy scale

    through study completion, an average of 20 minutes

  • Preparation for Decision Making scale

    through study completion, an average of 20 minutes

  • Information comprehension (proportion of participants providing a correct answer)

    through study completion, an average of 20 minutes

Other Outcomes (1)

  • Number of minutes to complete the questionnaire

    through study completion, an average of 20 minutes

Study Arms (3)

Vitruvian plot

EXPERIMENTAL
Device: Vitruvian plot

Kilim plot

EXPERIMENTAL
Device: Kilim plot

Summary of findings table

ACTIVE COMPARATOR
Device: Summary of findings table

Interventions

Visual (magnitude, uncertainty) and written (magnitude) communication tool / interventional decision-making aid tool

Vitruvian plot

Visual (uncertainty) and written (magnitude) communication tool / interventional decision-making aid tool

Kilim plot

Written (magnitude, uncertainty) communication tool / interventional decision-making aid tool

Summary of findings table

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged between 18 and 65 years (inclusive)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oxford Precision Psychiatry Lab (OxPPL)

Oxford, United Kingdom

Location

Related Links

MeSH Terms

Conditions

BehaviorLiteracy

Condition Hierarchy (Ancestors)

Communication

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2023

First Posted

June 26, 2023

Study Start

May 31, 2023

Primary Completion

November 27, 2023

Study Completion

November 27, 2023

Last Updated

December 18, 2023

Record last verified: 2023-12

Locations